1Tyers M, Mann M. From genomics to proteomics. Nature, 2003, 422(6928) : 193.
2Aebersold R, Cravett BF. Proteomics-advances, applications and the challenges the remain. Trends Biotechnol, 2002, 20( 12 suppl) : s1.
3Gauss C, Kalkum M, Lowe M, et al. Analysis of the mouse proteome.(1) Brain proteins: Separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis,1999, 20(3): 575.
4Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature,2003, 422(6928) : 198.
5Zhan XQ, Dominic M Desidefio. A reference map of a human pituitary adenmna proteome. Proteomics, 2003, 3(5): 699.
6Peryl A, Krapfenbauer K, Slavc Y, et al. Protein profiles of medulloblastoma cell lines DAOY and D283: Identification of tumor-related proteins and principles. Proteomics, 2003, 3(9) : 1781.
7Ribom D, Westman-Bfinkmalm A, Stairs A, et al. Elevated levels of alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas. Tumour Biol, 2003, 24(2): 94.
8Jenkins LW, Peters GW, Dixton CE, et al. Conventional and functional proteomics using large two-dlmenslonal gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J Neurotrauma, 2002,19(6) : 715.
9Maurer MH, Fetdmann RE, Futterer CD, et al. Re proteome of nerual stem cells from adult rat hippocampus. Proteome Sci, 2003, 1 ( 1 ) : 4.
10Pearee A, Svendsen CN. Charactefisation of stem cell expression using two-dimensional electrophoresis. Electrophoresis, 1999, 20(3) : 969.
